- Home
- RVPHW vs CCLDO Comparison
RVPHW vs CCLDO Comparison
Compare RVPHW & CCLDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- CCLDO
- Stock Information
- Founded
- RVPHW N/A
- CCLDO N/A
- Country
- RVPHW United States
- CCLDO United States
- Employees
- RVPHW 15
- CCLDO 3600
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- CCLDO Computer Software: Prepackaged Software
- Sector
- RVPHW Health Care
- CCLDO Technology
- Exchange
- RVPHW Nasdaq
- CCLDO Nasdaq
- Market Cap
- RVPHW N/A
- CCLDO N/A
- IPO Year
- RVPHW 2018
- CCLDO N/A
- Fundamental
- Price
- RVPHW $0.19
- CCLDO $16.60
- Analyst Decision
- RVPHW
- CCLDO
- Analyst Count
- RVPHW 0
- CCLDO 0
- Target Price
- RVPHW N/A
- CCLDO N/A
- AVG Volume (30 Days)
- RVPHW N/A
- CCLDO N/A
- Earning Date
- RVPHW N/A
- CCLDO N/A
- Dividend Yield
- RVPHW N/A
- CCLDO N/A
- EPS Growth
- RVPHW N/A
- CCLDO N/A
- EPS
- RVPHW N/A
- CCLDO N/A
- Revenue
- RVPHW N/A
- CCLDO N/A
- Revenue This Year
- RVPHW N/A
- CCLDO N/A
- Revenue Next Year
- RVPHW N/A
- CCLDO N/A
- P/E Ratio
- RVPHW N/A
- CCLDO N/A
- Revenue Growth
- RVPHW N/A
- CCLDO N/A
- 52 Week Low
- RVPHW N/A
- CCLDO N/A
- 52 Week High
- RVPHW N/A
- CCLDO N/A
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- CCLDO 73.17
- Support Level
- RVPHW N/A
- CCLDO $11.75
- Resistance Level
- RVPHW N/A
- CCLDO $18.48
- Average True Range (ATR)
- RVPHW 0.00
- CCLDO 0.73
- MACD
- RVPHW 0.00
- CCLDO 0.59
- Stochastic Oscillator
- RVPHW 0.00
- CCLDO 72.74
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About CCLDO CareCloud Inc.
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.